Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

IMMFF

Omni Bridgeway (PK) (IMMFF)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:IMMFF
DataOraFonteTitoloSimboloCompagnia
05/07/202201:40TipRanksGoldman Sachs Sticks to Their Buy Rating for Omni Bridgeway (IMMFF)USOTC:IMMFFOmni Bridgeway Ltd (PK)
15/03/202216:35TipRanksOmni Bridgeway (IMMFF) Receives a Buy from Goldman SachsUSOTC:IMMFFOmni Bridgeway Ltd (PK)
17/01/201316:25Edgar (US Regulatory)Revocation of Exchange Act Registration Pursuant to Section 12(j) (revoked)USOTC:IMMFFOmni Bridgeway Ltd (PK)
17/01/201306:00OTC MarketsRevoked SecurityUSOTC:IMMFFOmni Bridgeway Ltd (PK)
22/12/201206:00OTC MarketsTier ChangeUSOTC:IMMFFOmni Bridgeway Ltd (PK)
20/12/201206:00OTC MarketsSuspended SecurityUSOTC:IMMFFOmni Bridgeway Ltd (PK)
20/12/201206:00OTC MarketsCaveat Emptor Status ChangeUSOTC:IMMFFOmni Bridgeway Ltd (PK)
10/08/201111:00GlobeNewswire Inc.Immune Network to Start Clinical Trial of Oral Mycobacterium Vaccae in Tuberculosis PatientsUSOTC:IMMFFOmni Bridgeway Ltd (PK)
09/07/201112:57GlobeNewswire Inc.Immunitor Presents V5 Trial Data and Receives Award at TB Conference in Hong KongUSOTC:IMMFFOmni Bridgeway Ltd (PK)
07/07/201116:33GlobeNewswire Inc.Herbal TB Immunotherapy to be Presented at Hong Kong ConferenceUSOTC:IMMFFOmni Bridgeway Ltd (PK)
30/05/201116:14GlobeNewswire Inc.TB Immunotherapy Collaboration Agreement With Stirling Products and Zodiac CapitalUSOTC:IMMFFOmni Bridgeway Ltd (PK)
03/03/201116:07GlobeNewswire Inc.Ekomed Agrees to Collaboration on TB ImmunotherapyUSOTC:IMMFFOmni Bridgeway Ltd (PK)
28/02/201112:22GlobeNewswire Inc.Immunitor Presents Positive TB Treatment Data at African ConferenceUSOTC:IMMFFOmni Bridgeway Ltd (PK)
14/02/201111:57GlobeNewswire Inc.Immunitor CEO Joins Immune Network Board of DirectorsUSOTC:IMMFFOmni Bridgeway Ltd (PK)
24/01/201110:43GlobeNewswire Inc.Immunitor Releases Positive Results of TB Immunotherapy From Its Second Clinical SiteUSOTC:IMMFFOmni Bridgeway Ltd (PK)
17/01/201111:22GlobeNewswire Inc.Immunitor Deal Terms Approved by New Board of DirectorsUSOTC:IMMFFOmni Bridgeway Ltd (PK)
30/12/201010:41GlobeNewswire Inc.Immunitor Publishes Interim Data From Phase IIb imm01 TB TrialUSOTC:IMMFFOmni Bridgeway Ltd (PK)
13/12/201016:10GlobeNewswire Inc.Immunitor Completes Business Trip to China and Presents at Chinese Academy of Science Annual TB MeetingUSOTC:IMMFFOmni Bridgeway Ltd (PK)
29/11/201013:38GlobeNewswire Inc.Immunitor Awarded the Key U.S. Patent Related to Oral Vaccine Technology PlatformUSOTC:IMMFFOmni Bridgeway Ltd (PK)
15/11/201005:21GlobeNewswire Inc.Immunitor Completes Phase IIb imm01 Trial Enrollment and Plans Further Trials of V5USOTC:IMMFFOmni Bridgeway Ltd (PK)
01/11/201014:42GlobeNewswire Inc.Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next WeekUSOTC:IMMFFOmni Bridgeway Ltd (PK)
25/10/201013:29GlobeNewswire Inc.Immunitor Therapy is a Potential Breakthrough Against TuberculosisUSOTC:IMMFFOmni Bridgeway Ltd (PK)
16/09/201015:58GlobeNewswire Inc.Immune Network Ltd. Announces Intent to Acquire Oral Vaccine Technology PlatformUSOTC:IMMFFOmni Bridgeway Ltd (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:IMMFF
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network